The effect of transdermal scopolamine plus intravenous dexamethasone for the prevention of postoperative nausea and vomiting in patients with epidural PCA after major orthopedic surgery

Korean Journal of Anesthesiology

Volumn 58, Issue 1, 2010, Pages 50-55

  Lee, Hyun Kyu ^a   Lee, Jae Ho ^a   Chon, Sung Sik ^a   Ahn, Eun Kyoung ^a   Kim, Jin Ho ^a   Jang, Yeon Hee ^a  

^a National Health Insurance Corporation   (South Korea)

Author keywords

Dexamethasone; Epidural PCA; Major orthopedic surgery; PONV; Ramosetron; Transdermal scopolamine

Indexed keywords

ANTIEMETIC AGENT; DEXAMETHASONE; KIMITE; RAMOSETRON; SCOPOLAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DROWSINESS; EPIDURAL ANESTHESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; PROPHYLAXIS; SCORING SYSTEM; TRANSDERMAL PATCH; XEROSTOMIA;

EID: 77953419156     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2010.58.1.50     Document Type: Article

References (20)

1. White PF. Use of patient-controlled analgesia for management of acute pain. JAMA 1988; 259:243-7.
2. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77:162-84.
3. Kaufmann MA, Rosow C, Schnieper P, Schneider M. Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramide, and tropisetron. Anesth Analg 1994;78:988-94.
4. Renner UD, Oretel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005; 27:655-65.
5. Harnett MJ, O'Rourke N, Walsh M, Carabuena JM, Segal S. Transdermal scopolamine for prevention of intratheca morphine-induced nausea and vomiting after cesarean delivery. Anesth Analg 2007; 105: 764-9.
6. Kotelko DM, Rottman RL, Wright WC. Transderma scopolamine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology 1989; 71:675-8.
7. Bailey PL, Streisand JB, Pace NL, Bubbers SJ, East KA, Mulder S, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 1990; 72:977-80.
8. Honkavaara P, Saarnivaara L, Klemola UM. Effect of transdermal hyoscine on nausea and vomiting after surgical correction of prominent ears under general anaesthesia. Br J Anaesth 1995; 74:647-50.
9. Gan TJ, Sinha AC, Kovac AL, Jones RK, Cohen SA, Battikha JP, et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg 2009; 108:1498-504.
10. Sah N, Ramesh V, Kaul B, Dalby P, Shestak K, Vallejo MC. Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. J Clin Anesth 2009; 21:249-52.
11. Young S. Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver trytophan pyrrolase by hydroxycortisonefoles of tryptophane catabolism and kynurenine synthesis. Br J Pharmacol 1981 ; 74:695.
12. Fredrikson M, Hursti T, Furst CJ, Steineck G, Börjeson S, Wikblom M, et al. Nausea in cancer chemotherapy is inversely related to urinary Cortisol excretion Br J Cancer 1992; 65: 779-80.
13. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Granisetron/dexamethasone combination for reducing nausea and vomiting during and after spinal anesthesia for cesarean section. Anesth Analg 1999; 88:1346-50.
14. Lopez-Olaondo L, Carrascosa F, Pueyo FJ, Monedero P, Busto N, Saez A. Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting. Br J Anaesth 1996; 76:835-40.
15. Szarvas S, Chellapuri RS, Harmon DC, Owens J, Murphy D, Shorten GD. A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery. Anesth Analg 2003; 97:259-63.
16. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecological surgery. Anesth Analg 1999;89:476-9.
17. Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systemic review. Anesth Analg 2002; 95: 133-43.
18. White PF, Tang J, Song D, Coleman JE, Wender RH, Ogunnaike B, et al. Transdermal scopolamine: An alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptom. Anesth Analg 2007; 104:92-6.
19. Semple P, Madej TH, Wheatley RG, Jackson U, Stevens J. Transdermal hyosine with patient-controlled analgesia. Anaesthesia 1992;47:399-401.
20. Harris SN, Sevarino FB, Ginatra RS, Preble L, O'Conner TZ, Silverman DG. Nausea prophylaxis using transderma scopolamine in the setting of patient-controlled analgesia. Obstet Gynecol 1991 ; 78:673-7.